| |
|
|
Il-Yang Pharm. Co.,Ltd. (007570) |
|
|
STOCK |
|
|
| Address |
182-4, HAGAL-DONG, GIHEUNG-GU, YONGIN-SI, GYEONGGI |
| Home Page |
www.ilyang.co.kr
|
| Established |
1971.12.30 |
Tel |
031-281-7851 |
| Listed |
1974. 8.28 |
IR |
02-570-3767 |
| Common shares O/S |
14,102,526 |
President |
Jeong,Do Eon/Kim,Dong Yeon |
| Preferred shares O/S |
445,080 |
No.of Employees |
669(2009. 9) |
| Sales increased on the back of rising demand for its key products. The company swung to the black on reduced costs, but it is not enough to secure the trend. The company completed the first stage of clinical test of IY-5511, leukemia drug, and plans to launch a second stage of clinical test. |
| Sales are expected to increase as rising overseas demand for its key products. The company completed clinical tests of ulcer drug in six South Asian countries such as India. Financial status is expected to improve on rising profits and good cash flows. |
|
  |
(date: 2009.06, unit : %) |
| Name |
Jeong Doeon |
Jeong Yuseok |
Jeong Hyeongsik |
| Portion |
26.6 |
3.7 |
0.5 |
|
 |
(unit : %) |
| Sales |
DICETEL |
60.4 |
Cost |
Raw Materials |
|
| Diflucan,etc |
16.1 |
Labors |
|
| Others |
9.7 |
Overhead |
|
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
99. 6 |
99.10 |
~00. 3 |
00. 6 |
06. 7 |
| Type |
SD |
RI |
CB |
SD |
SS |
| Amount |
7.50 |
81.60 |
33.08 |
10.09 |
2,500.00 |
|
|
|
|
